| abstract |
A pharmaceutical composition containing as an active ingredient a compound selected from the group consisting of a component of formula (I), a component of formula (II), and salts thereof, the composition of which requires induction of apoptosis for treatment or prevention Diseases, cancer diseases, diseases requiring inhibition of free radical production for treatment or prevention, diseases requiring inhibition of nitric oxide production for treatment or prevention, diseases requiring inhibition of prostaglandin synthesis for treatment or prevention , A disease requiring inhibition of synovial cell proliferation for treatment or prevention, a disease requiring induction of heat shock protein production for treatment or prevention, or inhibition of α-glycosidase for treatment or prevention Therapeutic or prophylactic agents for diseases that require:n n n n n n n n n n n n n Wheren n n X and Y are H or CH 2 OH, provided that when X is CH 2 OH, Y is H, and when X is H, Y is CH 2 OH,n n n R is a residue obtained by releasing an SH group from an SH group-containing compound;n n n And foods, beverages, cosmetics, etc. containing a compound selected from the group consisting of a component of formula (I), a component of formula (II), and salts thereof. |